Tags: Cancer | brain | cancer | vaccine | glioblastoma | multiforme | life

Brain Cancer Hope: Vaccine Doubles Survival Rate

Tuesday, 01 Jul 2014 12:19 PM

 


Agenus Inc said its experimental cancer vaccine helped brain tumor patients live nearly twice as long compared with those who received standard of care treatment.
The drug, when given in addition to standard treatment, extended median overall survival in 50 percent of newly-diagnosed glioblastoma multiforme (GBM) patients to two years in a mid-stage study.
Usually GBM patients succumb to the disease in one year.

ALERT: Know These 3 Warning Signs You're About to Get Dementia

© 2015 Thomson/Reuters. All rights reserved.

1Like our page
2Share
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved